These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26462053)

  • 21. Invesgations [correction investigations] on the influence of halide substituents on the estrogen receptor interaction of 2, 4, 5-tris(4-hydroxyphenyl)imidazoles.
    Gust R; Busch S; Keilitz R; Schmidt K; Von Rauch M
    Arch Pharm (Weinheim); 2003 Oct; 336(10):456-65. PubMed ID: 14582122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From ligand structure to biological activity: modified estratrienes and their estrogenic and antiestrogenic effects in MCF-7 cells.
    Brooks SC; Skafar DF
    Steroids; 2004 Jun; 69(6):401-18. PubMed ID: 15219790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and estrogenic activity of a novel estrogen receptor modulator--a hybrid structure of 17beta-estradiol and vitamin E in hippocampal neurons.
    Zhao L; Jin C; Mao Z; Gopinathan MB; Rehder K; Brinton RD
    J Med Chem; 2007 Sep; 50(18):4471-81. PubMed ID: 17696335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and estrogenic activity of BODIPY-labeled estradiol conjugates.
    Peřina M; Börzsei R; Henrietta Ágoston ; Hlogyik T; Poór M; Rigó R; Özvegy-Laczka C; Batta G; Hetényi C; Vojáčková V; Jorda R; Mernyák E
    Eur J Pharm Sci; 2024 Aug; 199():106813. PubMed ID: 38797442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and biological evaluation of novel indole-xanthendione hybrids as selective estrogen receptor modulators.
    Singla R; Gupta KB; Upadhyay S; Dhiman M; Jaitak V
    Bioorg Med Chem; 2018 Jan; 26(1):266-277. PubMed ID: 29198894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of 4,4'-Diaminotriphenylmethanes with Potential Selective Estrogen Receptor Modulator (SERM)-like Activity.
    Guedes G; Amesty Á; Jiménez-Monzón R; Marrero-Alonso J; Díaz M; Fernández-Pérez L; Estévez-Braun A
    ChemMedChem; 2015 Aug; 10(8):1403-12. PubMed ID: 26076185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behavior.
    Pigeon P; Top S; Vessières A; Huché M; Hillard EA; Salomon E; Jaouen G
    J Med Chem; 2005 Apr; 48(8):2814-21. PubMed ID: 15828819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiestrogenically active 1,1,2-tris(4-hydroxyphenyl)alkenes without basic side chain: synthesis and biological activity.
    Lubczyk V; Bachmann H; Gust R
    J Med Chem; 2003 Apr; 46(8):1484-91. PubMed ID: 12672249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogenic and antiestrogenic activities of 2,4-diphenylfuran-based ligands of estrogen receptors alpha and beta.
    Zimmermann J; von Angerer E
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):259-68. PubMed ID: 17475477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of tamoxifen derivatives with a long alkyl side chain as selective estrogen receptor down-regulators.
    Shoda T; Kato M; Harada R; Fujisato T; Okuhira K; Demizu Y; Inoue H; Naito M; Kurihara M
    Bioorg Med Chem; 2015 Jul; 23(13):3091-6. PubMed ID: 26003343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigations on estrogen receptor binding. The estrogenic, antiestrogenic, and cytotoxic properties of C2-alkyl-substituted 1,1-bis(4-hydroxyphenyl)-2-phenylethenes.
    Lubczyk V; Bachmann H; Gust R
    J Med Chem; 2002 Nov; 45(24):5358-64. PubMed ID: 12431063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lead identification of a potent benzopyranone selective estrogen receptor modulator.
    McKie JA; Bhagwat SS; Brady H; Doubleday M; Gayo L; Hickman M; Jalluri RK; Khammungkhune S; Kois A; Mortensen D; Richard N; Sapienza J; Shevlin G; Stein B; Sutherland M
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3407-10. PubMed ID: 15177442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, biological evaluation, structural-activity relationship, and docking study for a series of benzoxepin-derived estrogen receptor modulators.
    Barrett I; Meegan MJ; Hughes RB; Carr M; Knox AJ; Artemenko N; Golfis G; Zisterer DM; Lloyd DG
    Bioorg Med Chem; 2008 Nov; 16(21):9554-73. PubMed ID: 18835176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer.
    Rasmussen LM; Zaveri NT; Stenvang J; Peters RH; Lykkesfeldt AE
    Breast Cancer Res Treat; 2007 Dec; 106(2):191-203. PubMed ID: 17268816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenging Approach to the Development of Novel Estrogen Receptor Modulators Based on the Chemical Properties of Guaiazulene.
    Ohta K; Kaise A; Ogawa T; Endo Y
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and biological evaluation of novel 2-methoxyestradiol analogs as dual selective estrogen receptor modulators (SERMs) and antiangiogenic agents.
    Lao K; Wang Y; Chen M; Zhang J; You Q; Xiang H
    Eur J Med Chem; 2017 Oct; 139():390-400. PubMed ID: 28810190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of 2,3,5-triaryl-1H-pyrroles as estrogen receptor α selective ligands.
    Schäfer A; Wellner A; Strauss M; Wolber G; Gust R
    ChemMedChem; 2011 Nov; 6(11):2055-62. PubMed ID: 21990277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues.
    Saha P; Descôteaux C; Brasseur K; Fortin S; Leblanc V; Parent S; Asselin E; Bérubé G
    Eur J Med Chem; 2012 Feb; 48():385-90. PubMed ID: 22209414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unique SERM-like properties of the novel fluorescent tamoxifen derivative FLTX1.
    Marrero-Alonso J; Morales A; García Marrero B; Boto A; Marín R; Cury D; Gómez T; Fernández-Pérez L; Lahoz F; Díaz M
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):898-910. PubMed ID: 23727370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-Chain.
    Sharma A; Toy W; Guillen VS; Sharma N; Min J; Carlson KE; Mayne CG; Lin S; Sabio M; Greene G; Katzenellenbogen BS; Chandarlapaty S; Katzenellenbogen JA
    ACS Chem Biol; 2018 Dec; 13(12):3374-3384. PubMed ID: 30404440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.